234 related articles for article (PubMed ID: 28131278)
1. Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases.
Bjurström CF; Mojadidi M; Phillips J; Kuo C; Lai S; Lill GR; Cooper A; Kaufman M; Urbinati F; Wang X; Hollis RP; Kohn DB
Mol Ther Nucleic Acids; 2016; 5(8):e351. PubMed ID: 28131278
[TBL] [Abstract][Full Text] [Related]
2. TALENs-an indispensable tool in the era of CRISPR: a mini review.
Bhardwaj A; Nain V
J Genet Eng Biotechnol; 2021 Aug; 19(1):125. PubMed ID: 34420096
[TBL] [Abstract][Full Text] [Related]
3. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 Editing of the
Sharma A; Boelens JJ; Cancio M; Hankins JS; Bhad P; Azizy M; Lewandowski A; Zhao X; Chitnis S; Peddinti R; Zheng Y; Kapoor N; Ciceri F; Maclachlan T; Yang Y; Liu Y; Yuan J; Naumann U; Yu VWC; Stevenson SC; De Vita S; LaBelle JL
N Engl J Med; 2023 Aug; 389(9):820-832. PubMed ID: 37646679
[TBL] [Abstract][Full Text] [Related]
6. Origins of Programmable Nucleases for Genome Engineering.
Chandrasegaran S; Carroll D
J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
[TBL] [Abstract][Full Text] [Related]
7. Gene editing and its application for hematological diseases.
Osborn MJ; Belanto JJ; Tolar J; Voytas DF
Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
[TBL] [Abstract][Full Text] [Related]
8. The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy.
Cui Z; Liu H; Zhang H; Huang Z; Tian R; Li L; Fan W; Chen Y; Chen L; Zhang S; Das BC; Severinov K; Hitzeroth II; Debata PR; Jin Z; Liu J; Huang Z; Xie W; Xie H; Lang B; Ma J; Weng H; Tian X; Hu Z
Mol Ther Nucleic Acids; 2021 Dec; 26():1466-1478. PubMed ID: 34938601
[TBL] [Abstract][Full Text] [Related]
9. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Gaj T; Gersbach CA; Barbas CF
Trends Biotechnol; 2013 Jul; 31(7):397-405. PubMed ID: 23664777
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
11. Application of genome editing technologies to the study and treatment of hematological disease.
Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
[TBL] [Abstract][Full Text] [Related]
12. Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus).
Aluru N; Karchner SI; Franks DG; Nacci D; Champlin D; Hahn ME
Aquat Toxicol; 2015 Jan; 158():192-201. PubMed ID: 25481785
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Engraftment and Fetal Globin Induction upon
Chang KH; Smith SE; Sullivan T; Chen K; Zhou Q; West JA; Liu M; Liu Y; Vieira BF; Sun C; Hong VP; Zhang M; Yang X; Reik A; Urnov FD; Rebar EJ; Holmes MC; Danos O; Jiang H; Tan S
Mol Ther Methods Clin Dev; 2017 Mar; 4():137-148. PubMed ID: 28344999
[TBL] [Abstract][Full Text] [Related]
15. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
16. Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells.
Peterson CW; Venkataraman R; Reddy SS; Pande D; Enstrom MR; Radtke S; Humbert O; Kiem HP
Mol Ther Methods Clin Dev; 2022 Mar; 24():30-39. PubMed ID: 34977270
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
18. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
19. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
20. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
